Insider · CIK 0001863024

Carter Percy H.

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001863024

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-07-17	Blueprint Medicines CorpD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−56.6K sh	—	—	17,894
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−39.2K sh	—	—	0
2025-07-17	Blueprint Medicines CorpU Disposition from Tender	Chief Scientific Officer	UDisposition from Tender	−17.9K sh	—	—	0
2025-07-17	Blueprint Medicines CorpA Award	Chief Scientific Officer	AAward	+21.4K sh	—	—	74,508
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−22K sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−25K sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−25K sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−17.5K sh	—	—	0
2025-07-03	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−1,051 sh	$128.25	−$135K	53,155
2025-06-03	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−2,418 sh	$127.88	−$309K	54,206
2025-06-03	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−241 sh	$127.88	−$30.8K	56,624
2025-03-05	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−3,530 sh	$88.80	−$313K	56,865
2025-03-01	Blueprint Medicines CorpA Award	Chief Scientific Officer	AAward	+11K sh	—	—	60,395
2025-03-01	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+22K sh	—	—	22,000
2024-07-01	Blueprint Medicines CorpA Award	Chief Scientific Officer	AAward	+7,500 sh	—	—	49,395
2024-06-05	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−4,000 sh	$105.13	−$421K	41,895
2024-06-03	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−2,436 sh	$106.43	−$259K	45,895
2024-03-07	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−2,286 sh	$90.69	−$207K	48,331
2024-03-01	Blueprint Medicines CorpA Award	Chief Scientific Officer	AAward	+12.5K sh	—	—	50,617
2024-03-01	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+25K sh	—	—	25,000
2023-06-05	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−2,307 sh	$52.06	−$120K	38,117
2023-03-06	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−736 sh	$45.72	−$33.6K	40,449
2023-03-06	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−25 sh	$44.78	−$1,119.5	40,424
2023-03-01	Blueprint Medicines CorpA Award	Chief Scientific Officer	AAward	+12.5K sh	—	—	41,185
2023-03-01	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+25K sh	—	—	25,000
2022-06-06	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−1,908 sh	$59.76	−$114K	28,685
2022-03-01	Blueprint Medicines CorpA Award	Chief Scientific Officer	AAward	+8,750 sh	—	—	30,593
2022-03-01	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+17.5K sh	—	—	17,500
2021-06-01	Blueprint Medicines CorpA Award	Chief Scientific Officer	AAward	+21.8K sh	—	—	21,843
2021-06-01	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+39.2K sh	—	—	39,200

Recent filings

Accepted (ET)
Jul 214
Carter Percy H.0001104659-25-069388
SEC(opens sec.gov)
Jul 84
Carter Percy H.0001415889-25-019506
SEC(opens sec.gov)
Jun 54
Carter Percy H.0001415889-25-015767
SEC(opens sec.gov)
Mar 74
Carter Percy H.0001415889-25-007375
SEC(opens sec.gov)
Mar 44
Carter Percy H.0001415889-25-006604
SEC(opens sec.gov)
Jul 84
Carter Percy H.0001415889-24-019391
SEC(opens sec.gov)
Jun 74
Carter Percy H.0001415889-24-015943
SEC(opens sec.gov)
Jun 54
Carter Percy H.0001415889-24-015540
SEC(opens sec.gov)
Mar 114
Carter Percy H.0001415889-24-007552
SEC(opens sec.gov)
Mar 64
Carter Percy H.0001415889-24-007009
SEC(opens sec.gov)

Companies

Blueprint Medicines CorpChief Scientific Officer

Address

C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET

CAMBRIDGE, MA, 02139